"The biological mechanism of resistance identified in certain subjects cannot be synthesised through conventional pharmaceutical means. The resistance pathway is endogenous — specific to individual biology. Replication attempts have failed across ████████████ trials. Source biology must be located and secured before viable therapeutic pathway can be established. Research suspended per Directive 2051-44.

Note: clinical presentation is an unreliable indicator of disease progression. Individuals may exhibit minimal visible surface markers for years while systemic organ degradation advances silently. Internal tissue damage precedes visible dissolution by an estimated 18–36 months in Fitzpatrick Type V–VI subjects. Surface staging should not be used as a proxy for internal disease burden."